Tag: CBT > Cannabis Rescheduling

Cannabis Rescheduling

Where Are We on Cannabis Rescheduling? It’s Been Months Since the US Attorney General’s April 2026 Order

There’s been no transparency about the applications of those seeking DEA registration. The IRS/Treasury has provided no guidance about what to do regarding §280E on those federal tax returns – even though, in April, the feds promised it would be forthcoming.

September 11, 2026

Cannabis Rescheduling

Federal Court Denies Anti-Rescheduling Parties’ Motion to Stay Schedule III Cannabis Order

The U.S. Court of Appeals for the District of Columbia Circuit won’t halt the Trump administration’s order that reclassified medical cannabis.

September 10, 2026

Cannabis Rescheduling

Will Judge’s Rescheduling Decision Be Influenced by Lone Opposed Party Witness DEA Did Not Discredit?

Some legal experts believe a pharmacologist’s testimony on currently accepted medical use could be the most damning for the Schedule III proposal.

August 28, 2026

Cannabis Rescheduling

DEA’s Final Schedule III Case Leads CBT’s Top Stories in August

The Drug Enforcement Administration tried to discredit nearly all opposing witnesses who testified during the rescheduling hearing in its post-hearing brief.

August 27, 2026

Cannabis Rescheduling

DEA Judge Releases Transcripts for Cannabis Rescheduling Hearing

With the fully corrected transcripts now part of the public record, the judge who oversaw the hearing’s proceedings now must make a recommendation.

August 25, 2026

Cannabis Rescheduling

DEA Judge Orders 294 Corrections to 2,500-Page Cannabis Hearing Transcript

The DEA’s administrative law judge said the fully corrected transcript for the cannabis rescheduling hearing will be made public no later than Aug. 26.

August 21, 2026

Cannabis Rescheduling

US House Members Push Trump Administration for Guidance on Schedule III Federal Framework

A bipartisan quartet of lawmakers sent a letter to Trump and three cabinet members, asking for clarity on the federal policy for medical cannabis.

August 19, 2026

Cannabis Rescheduling

DEA Makes Final Schedule III Case, Tries to Discredit Nearly All Opposing Witnesses

The government’s final brief for the cannabis rescheduling hearing focuses on currently accepted medical use, a scientific and medical analysis, and the opposition’s ‘so-called experts.’

August 19, 2026

Cannabis Rescheduling

What to Expect From the DEA’s Cannabis Rescheduling Hearing Transcripts, Final Briefs

A law judge’s recommendation may not come down to whether anti-rescheduling parties proved a Schedule I listing, but whether they disproved the government’s Schedule III evidence.

August 5, 2026

Top Stories

Idaho’s Cannabis Legalization Campaign Effort Leads CBT’s Top Stories in July

Activists submitted signatures to the state secretary at the beginning of the month, after collecting more than double the required number for their petition.

July 29, 2026

Federal Cannabis Legalization

Project Four 2029 Launches to Build Legal Case for Federal Cannabis Rescheduling Ahead of 2029

The new nonpartisan advocacy initiative pairs legal precision with public strategy to prepare the ground for reform before the political window opens.

July 29, 2026

Cannabis Rescheduling

Anti-Rescheduling Groups Attempting to Stay Schedule III Order Call Government’s Response ‘Meritless’

A drug testing group and pharmaceutical company asked a federal court to stay the order, claiming the DOJ has no defense other than diversions.

July 17, 2026